Lymphoma Working Party (LWP)
Study number:
2020-R-03
Short title:
Allo HSCT For HL in the era of Checkpoint Inhibitors
Primary objective:
Key inclusion criteria:
Country:
Principal investigator:
Miguel-Angel Perales
EBMT Study coordinator:
Hervé Finel
Study coordinator email:
herve.finel@upmc.fr